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Background: The overall prevalence of infertility was estimated to be 3.5–16.7% in developing countries and
6.9–9.3% in developed countries. Furthermore, according to reports from some regions of sub-Saharan Africa, the
prevalence rate is 30–40%. The consequences of infertility and how it affects the lives of women in poor-resource
settings, particularly in developing countries, has become an important issue to be discussed in reproductive
health. In some societies, the inability to fulfill the desire to have children makes life difficult for the infertile couple.
In many regions, infertility is considered a tragedy that affects not only the infertile couple or woman, but the
entire family.
Methods: This is a position paper which encompasses a review of the needs of low-income infertile couples,
mainly those living in developing countries, regarding access to infertility care, including ART and initiatives to
provide ART at low or affordable cost. Information was gathered from the databases MEDLINE, CENTRAL, POPLINE,
EMBASE, LILACS, and ICTRP with the key words: infertility, low income, assisted reproductive technologies,
affordable cost, low cost.
Results: There are few initiatives geared toward implementing ART procedures at low cost or at least at affordable
cost in low-income populations. Nevertheless, from recent studies, possibilities have emerged for new low-cost
initiatives that can help millions of couples to achieve the desire of having a biological child.
Conclusions: It is necessary for healthcare professionals and policymakers to take into account these new
initiatives in order to implement ART in resource-constrained settings.
Keywords: Infertility, Assisted reproductive technologies, Low cost, InequityBackground
The prevalence of infertility has been calculated as ran-
ging from 4 to 14% worldwide, and the international
consensus is that 8–10% of cohabiting couples are infer-
tile, with variations in this percentage according to the
region considered [1-4]. In 2002, in an analysis of data
from demographic and health surveys in developing coun-
tries (excluding China), it was estimated that more than
186 million women who were married or in a stable union
and of reproductive age presented primary or secondary
infertility problems [5]. An analysis of 25 population-
based surveys estimated the overall prevalence of infertility* Correspondence: bahamond@caism.unicamp.br
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article, unless otherwise stated.to be 3.5–16.7% in developing countries and 6.9–9.3% in
developed countries [6,7]. Furthermore, according to re-
ports from some regions of sub-Saharan Africa, the preva-
lence rate is 30–40% [8].
It has also been estimated that around 5% of the world
population decides voluntarily to be childless and does
not choose the parental role as part of personal and
adult development. Therefore, it may be legitimate to
think that parenthood is socially expected and continues
to be an important objective of the life project, consid-
ered part of personal development and adult life among
most men and women in the world [9-16].
In a predominantly fertile world, it is expected that
pregnancy will occur when men and women decide to
become parents, and it is surprising when this does notoMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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tion of the life project and a social situation that differs
from the majority. Involuntary childlessness is considered
a major life issue associated with psychological suffering
and long-term consequences. Women who desire a child
and cannot achieve pregnancy perceive themselves as dif-
ferent from women who are fertile, and feel they are losing
something important in their lives [17-20]. The diagnosis
of infertility may become a life crisis, and most couples
need to develop mechanisms to cope with the temporary
or permanent loss of fertility and the possibility of having
a biological child [17,21,22]. After diagnosis, men and
women have feelings of loss of control over their life pro-
ject, and feel they are unable to achieve their life expecta-
tions [17,18,23-25].
Infertile couples may have difficulty communicating
their feelings to family and friends with children because
they do not perceive a comprehensive social environ-
ment to understand their situation [13,26-28]. Fre-
quently, they feel alone and without support to deal with
the experience of infertility, and a need for sharing ex-
perience with other infertile couples, guidance through
the treatment process, and written information about
practical and emotional aspects of treatment to help
them through the experience of infertility [29].
Over the last decades, many women have married or
established stable relationships after achieving other life
goals such as a career and financial stability, postponing
the desire to have children. The mean age of women at
the time of their first pregnancy has increased in recent
years, and in the last decade was 28–29 years old in
most of western hemisphere countries. In this scenario,
many women try to become pregnant with their first
child when fertility starts to decline and the risk of infer-
tility is higher [30].
The consequences of infertility and how it affects the
lives of women in poor-resource settings, particularly in
developing countries, has become an important issue to
be discussed in reproductive health. In some societies, the
inability to fulfill the desire to have children, together with
the social stigma associated with infertility, makes life diffi-
cult for the infertile couple. In many regions, infertility is
considered a tragedy that affects not only the infertile
couple or woman, but the entire family [13,31,32].
Many societies still view infertility as affecting only the
women, and those who are childless are frequently
neglected or exposed to humiliation and domestic vio-
lence [33-38]. Furthermore, this situation and their own
suffering because of the impossibility of conceiving a child
may lead to diverse psychological problems, such as dis-
tress, anxiety, depression, low self-esteem, feelings of
blame and guilt, and reduced sexual interest [33,37,39-41].
Seeking for solutions, when there are no services avail-
able in the public sector or at an affordable cost, womenmay be induced to seek ineffective therapies [37,39,41].
Consequently, access to the diagnosis and treatment of
infertility, including assisted reproductive technologies
(ART), contributes to resolving social inequities and emo-
tional difficulties. Infertility is more than a health problem;
it is a social issue and a public health matter [42].
The treatment of infertility in low-resource settings is
a challenge for policymakers and the health system.
However, it is mainly a human rights issue: All men and
women who desire to have children, to have a family,
and not to be different from most of the individuals of
their social environment should have the opportunity to
solve this problem. The poorest sector of the popula-
tions of developing countries are probably those more
prone to infertility due to poverty, poor education, early
sexual debut, no access to services for counseling and
treatment when necessary, unsafe abortion [37], among
other factors. Probably, they represent the population
most in need of ART [43-47].
More than 30 years have elapsed since the first publi-
cation reporting the birth of a child after in vitro
fertilization (IVF) [48], much research has been done,
and other techniques like intracytoplasmic sperm injec-
tion (ICSI) have emerged. ART has brought great hope
to many couples, who have referred to this technique as
their last chance of having a child that is biologically re-
lated to them [49].
Although ART is a common treatment for infertile
couples worldwide, the availability of such procedures is
lacking in developing countries; even in developed coun-
tries, low-income couples have great difficulties of access
due to the high cost charged by private clinics and the
lack of services offered by the public sector [45,47,50].
Methods
This is a position paper which encompasses a review of the
needs of low-income infertile couples, mainly those living
in developing countries, regarding access to infertility care,
including ART and initiatives to provide ART at low or af-
fordable cost. Information was gathered from the databases
MEDLINE, CENTRAL, POPLINE, EMBASE, LILACS, and
ICTRP with the key words: infertility, low income, assisted
reproductive technologies, affordable cost, low cost.
Infertility: medical causes
Approximately one-third of infertility cases are due to
the male factor, one-third to the female factor and the
remaining third to a combination of male and female
factors or to unidentified causes [51]. In settings with
poor access to health services, common causes of infer-
tility are post-partum and post-abortion infections, tu-
berculosis, and sexually transmitted infections (STIs)
[52]. Infertility can also be a consequence of infections
after female genital circumcision [53].
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mon practice and adolescent pregnancy rates are high.
This early age of sexual debut may be related to a high
prevalence of reproductive tract infection (RTI), and
consequently both male and female infertility [2,3,6].
The prevalence of male and female RTI, and the infertil-
ity which may consequently occur, is high in developing
countries [53,54], and the best way to reduce this inci-
dence is through prevention and RH education, an im-
portant task for governments; however, this represents
a challenge [45-47], because education is a long-term
process and individuals who are infertile because they do
not use means of prevention need to be treated. It is well-
known that tubal obstruction was the first diagnosis for
which IVF was developed and indicated, and RTI often
provokes tubal obstruction. The fact that this cause of in-
fertility is more common in developing areas and among
low-income populations is an indicator of the necessity of
implementing ART in low-income populations.
Access to infertility health care
As part of the United Nations (UN) Program of Action,
consensus was reached on a comprehensive concept of
RH that includes the right of men and women to choose
the number, timing, and spacing of the children they de-
sire to have. This Program of Action includes the need to
incorporate family planning programs, the prevention and
treatment of RTI, and the prevention and treatment of in-
fertility as part of RH services [55]. Furthermore, the
Millennium Developments Goals of the UN 2000 estab-
lished universal access to RH as one of the targets to be
achieved by 2015 [56]. Infertility is one of the neglected
aspects of RH care, particularly in developing countries. In
many developing countries, infertile couples with limited
resources are confronted with difficulties and very re-
stricted possibilities of gaining access to infertility services
within the public health sector [26,45-47].
The urgent need for many women to resolve their child-
lessness is a situation that increases the demand from poor
couples in developing countries for good quality infertility
care [33]. Delays in gaining access to the diagnosis of infer-
tility, to infertility services and to services that offer ART
may negatively affect the possibility and the success of
treatment for many couples. Access to diagnosis and treat-
ment for infertility, including ART procedures, contributes
to diminishing inequities, and may reduce suffering related
to the difficulty of access and emotional suffering due to
infertility. This represents a step forward in guaranteeing
the right of women and men to decide when they desire to
have children and to help infertile couples to have at least
one biological child [55,56].
More than a decade ago, the World Health Organization
(WHO) recommended that infertility must be considered
a global health problem and also recommended thedevelopment of initiatives to improve access to infertility
services and the care of infertile couples, including the de-
velopment of low-cost ART [57]. Although this is still not
sufficient and is far from representing a solution, some ini-
tiatives have been implemented to reduce the burden of
infertility [7,33,57-60]. In this context, the European Soci-
ety for Human Reproduction and Embryology (ESHRE)
created a Task Force on Infertility and Developing Coun-
tries with the objective of explore new approaches to ART
that will be useful in developing settings [61].
The nonexistence of infertility care in resource-
constrained settings has been justified many times by the
fact that other important and life-threatening health issues
are a priority in the health sector, including maternal mor-
bidity and mortality, vaccination, malaria, dengue fever,
yellow fever, and the drugs required for people living with
HIV and AIDS [54,62,63]. The implementation of infertil-
ity care, including affordable ART treatment, frequently
represents a challenge; an understanding of the impact in-
fertility has on the life of men, and particularly women,
not only as a health problem but an emotional and social
problem, as well as strong political commitment, is needed
for action. According to the WHO [54], ‘relatively few of
the world’s infertile men and women can be said to have
complete and equitable access to the complete range of in-
fertility treatments at affordable levels’.
Simplified procedures for ART
Many new initiatives to reduce the cost of ART proce-
dures without hampering the results in terms of preg-
nancy rates and number of babies taken home have been
developed over the last 10 years. However, despite the
efforts to make these procedures available at affordable
cost, efforts are still scarce; most of the procedures come
from developed countries, and are still not translate into
actions in many settings.
Many professionals working with ART procedures use
controlled ovarian stimulation and follicle development
with gonadotropin-releasing hormone (Gn-RH) analogues
or antagonist and with gonadotropins in order to develop
many ovarian follicles to obtain more embryos, and conse-
quently have the possibility to transfer more than one em-
bryo to maximize the possibility of pregnancy. However,
in recent years, there have been many reports presenting
reliable data on low-cost ART with acceptable pregnancy
rates, and in some cases, rates that are similar to those ob-
tained with high-cost procedures [64,65].
Low cost does not necessarily jeopardize the quality of
the procedures. Low-cost ART is based on the use of af-
fordable stimulation protocols, clinical judgment rather
than sophisticated laboratory testing, reduction or elim-
ination of all superfluous pre-procedure investigations,
careful use of disposable materials, and well-established
protocols for laboratory routines. It has to be taken into
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the necessity of the infrastructure of a good laboratory.
The use of the natural cycle or simplified ovarian
stimulation ART treatment can reduce the cost of drugs,
as well as the possibility of multiple pregnancies. How-
ever, to the best of our knowledge, there are no random-
ized clinical trials comparing natural cycle ART with
standard ART. A recent review [66] showed that there is
no evidence that clomiphene citrate (CC) versus gonad-
otropins and Gn-RH analogue or antagonists are equiva-
lent in terms of follicular development. Nevertheless,
CC is still the drug used in many protocols to reduce
cost. It is well established that CC mimics the effects of
Gn-RH analogue and prevents the luteinizing hormone
(LH) surge [64].
A group of researchers [67] used CC (50 mg daily)
with intermittent doses of human menopausal gonado-
tropin (hMG) 150 IU on alternate days from the 5th day
onwards; follicular development was monitored only
with pelvic ultrasound. The researchers performed em-
bryo transfer for more than two-thirds of the women
and showed that with this protocol, birth and clinical
pregnancy rates per embryo transfer were similar to
those expected with high-cost procedures. The average
direct cost per cycle was US$ 675 for IVF and US$ 725
for an ICSI cycle.
Whether the use of low dose of CC in ART reduces
premature ovulation rate and increases the transfer rate
was also evaluated [68]. Women who underwent one
natural-IVF cycle with human chorionic gonadotropin to
induce ovulation were compared with women who
underwent one natural-IVF cycle with 25 mg/day CC for
almost 7 days. Women who used CC presented a signifi-
cantly lower premature ovulation rate in comparison to
those who did not use it and the transfer rate was higher
among the CC group in comparison to women who did
not use CC. Clinical pregnancy rates were not signifi-
cantly different between groups.
Another low-cost strategy is the transfer of a single
embryo. A Japanese-based study [69] assessed a cohort
of more than 7,000 women who received a single-
embryo transfer according to age (≤29, 30–34, 35–39,
40–44, and ≥ 45 years) who performed 20,244 cycles
with a CC stimulation or natural-IVF cycle. Fertilization
(80.3%) and cleavage (91.1%) rates were not significantly
different among different age groups; however, overall
live birth rate decreased as age increased, and was no
higher than 1% in women aged 45 years or older. The
results showed that single embryo transfer could be a
strategy to reduce the cost of ART cycles.
Lopez-Regalado and co-workers [70] evaluated the
pregnancy rate with single embryo transfer versus
double embryo transfer among women under 38 years
old. The cumulative live birth delivery rate in the singleembryo transfer group was similar to the women who
received double embryo transfer. Additionally, multiple
gestations were significantly lower in the group who was
treated with single embryo transfer than the other group
(0% vs. 26.4%; P < .05). Rate of implantation, cumulative
pregnancy rates per transfer, and cumulative live birth
delivery were similar among both groups. Similar results
were obtained in other settings [71,72]. In a recent
Cochrane review [73], the policy of single embryo trans-
fer versus two embryo transfer was evaluated regarding
pregnancy rates. The authors concluded that if a single
fresh embryo is transferred, it is associated with a lower
live birth rate than double embryo transfer. Neverthe-
less, they also observed no significant differences when
single and double embryo transfer re compared regarding
cumulative the live birth rate with repeated single embryo
transfer, involving either two cycles of fresh single versus
one cycle of fresh single embryo followed by one frozen
single embryo in a natural or hormone-stimulated cycle.
Furthermore, it was observed that single embryo transfer
was linked to lower rates of multiple pregnancies which it
is important in baby survival and cost of use of the inten-
sive care unit. However, the evidence is related to young
women without a poor prognosis.
Some years ago, a very low-cost ART procedure was
reported in which the gametes and embryos were incu-
bated in a capsule in the woman’s vagina, thereby avoid-
ing the use of expensive and complex laboratory. This
procedure resulted in adequate pregnancy rates of 19%
per cycle [74].
In this vein, a recent case-series report [75] described
the results of a pilot trial that involved a simplified la-
boratory method for human IVF. The described system
reproduces the atmospheric and culture conditions for
fertilization and pre-implantation embryogenesis, with
no need for a culture chamber with gases. Using the de-
scribed culture system, 8 out of 23 embryos implanted,
one miscarried at eight weeks of gestation, and seven ba-
bies were born.
This simplified system could be incorporated world-
wide to improve the capacity of offering ART at afford-
able cost in low-resource settings. There is no doubt
that this strategy does not resolve all the issues involved
in low-cost ART; however, it is a big step forward to
help services to implement ART at affordable cost in
low-income settings. The authors estimated that the first
cost of a single IVF cycle using these methodologies and
protocols must be less than 200 € [76].
Comments
In developing countries and poor-resource settings, in-
fertility care and treatment that includes access to ART
at low cost or at least at affordable costs for the under-
privileged segments of society is a neglected RH issue in
Bahamondes and Makuch Reproductive Biology and Endocrinology 2014, 12:87 Page 5 of 7
http://www.rbej.com/content/12/1/87public health in most countries. Services are mainly
available in the private sector at a high cost for the ma-
jority of the population [33,50,61]. Frequently, health au-
thorities and governments justify this neglected health
issue and the lack of infertility services based on the fact
that there are other urgent, life-threatening health prob-
lems to consider [55]. This suggests that many policy-
makers are not aware of the profound implications of
infertility in the lives of individuals, couples, and fam-
ilies. Furthermore, in some settings, when unattended,
this health issue may become a source of discrimination,
abandonment, and violence, particularly for women.
Even in some settings in developed countries, for low-
income populations like Latinos and African-American
descendants in the United States (US) [77] or migrants
in the European Union [78], infertility diagnosis and
treatment including ART is a neglected RH issue. As an
example of this inequity, a US survey [79,80] evaluated
more than 4,000 couples to assess the likelihood of seek-
ing an infertility evaluation and infertility treatment.
Among those seeking an evaluation, only 50% reported
they had undergone any treatment. Low income, em-
ployment status, and non-white ethnicity were strongly
correlated with the possibility of not seeking treatment;
among those who received treatment, only a small pro-
portion was treated with ART.
ART is an excellent solution for many infertile couples
who cannot conceive the desired child by other treat-
ments. High-quality ART procedures at no cost for pa-
tients or at an affordable cost to the underprivileged
segment of the society is a moral and social obligation of
governments that have promised to improve and provide
RH services that are accessible to most sectors of the
population [54]. Twenty years have elapsed from United
Nations International Conference on Population and De-
velopment [56] and it is necessary to take initiatives to
offer treatments to infertile couples that include ART
procedures, improved access to the underprivileged
population, and the guarantee of well-equipped and
competently staffed infertility centers.
The lack of ART services at low or affordable cost in-
creases the practice of couples seeking these procedures
outside their country of residence. A new phenomenon of
cross-border reproductive care can be observed world-
wide, and many questions are emerging, mainly regarding
whether patients traveling abroad for ART procedures are
at any risk and if there is a really cost-benefit result. In
addition, it is not clear whether the healthcare profes-
sionals (HCPs) who offer this kind of service advise poten-
tial patients of the real pregnancy rates, complications,
offspring risks, or of the availability of gamete donors and
surrogate mothers, among other thing [81].
The fact that there is a respectable body of research
showing the effectiveness of low-cost technology withthe aim of facilitating the inclusion of ART in restricted-
resource settings does not guarantee the implementation
of these strategies in infertility services. There seems to
be a gap between the development of low-cost ART
technology and the use of these strategies in a clinical
context. The results of recent research on the new low-
cost and simplified ART system for culturing gametes
without the needs of a sophisticated laboratory [76] are
encouraging, because this work addresses a fundamental
obstacle for millions of couples worldwide, namely access
to ART at very low or at least affordable cost [77,82]. It is
obvious that further studies are needed to validate these
early results and to replicate them in different settings. As
stated, it is necessary to evaluate the real cost, mainly in
relation to hidden costs (personnel and infrastructure)
[82]; however, any reduction in cost will be a great step for
many couples.
The introduction of these technologies requires a spe-
cialized, organized medical and paramedical staff; a
minimum of infrastructure within the health system—re-
garding the supply of materials and improvement in
existing services—is necessary. Moreover, patients and
staff need to interact with a cooperative understanding.
HCPs need to explain clearly the specific characteristics
of the treatment, the real possibilities of pregnancy, and
potential risks to their patients, and must respect cul-
tural and religious beliefs. Patients, on the other hand,
need to follow the medication scheme and the intricate
rules of these procedures carefully.
Given the magnitude of the problem—the number of
people all over the world who suffer from infertility, the
impact infertility has on people’s lives, and that ART is
presently out of the reach for the majority of those who
need it—it is legitimate to question the extent to which
initiatives have to be carried out for these procedures to
become part of national infertility policies. This is an
issue for each country to resolve. However, as Fathalla
et al. [83] stated almost a decade ago, it is time to cross
the boundary from talking and writing to taking action.
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